Claassen Cassidy W, Mabuto Tonderai, Shearer Kate, Park Jane, Willkens Megan, Bwalya Chiti, Issarow Benson, Kanyama Cecilia, Peck Rob N, Vinikoor Michael, Hoffmann Christopher J
Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Curr HIV/AIDS Rep. 2025 Aug 7;22(1):42. doi: 10.1007/s11904-025-00752-1.
PURPOSE OF REVIEW: Death following hospitalization remains strikingly high for people living with HIV (PLHIV) in sub-Saharan Africa. Hospitalization represents a key opportunity for targeted interventions, yet evidence for effective approaches remains limited. We conducted a best-evidence narrative review, framed by the Andersen Model of Health Care Utilization, to examine factors contributing to post-hospital mortality and assess recent interventions. RECENT FINDINGS: PLHIV in sub-Saharan Africa have a 12-26% risk of death within 3-6 months of discharge. Social and structural barriers-including poverty, stigma, food insecurity, and low self-efficacy-are central mediating factors. We reviewed three disease-neutral interventions (HomeLink, Daraja, ReCharge) providing home-based support, counseling, and care linkage. While feasible and acceptable, mortality impact was mixed due to small sample sizes and advanced illness. The hospital-to-home transition is a critical window for intensified differentiated services to reduce mortality among PLHIV. Further research is needed to define scalable and cost-effective models to improve survival and close gaps in HIV care.
综述目的:在撒哈拉以南非洲地区,感染艾滋病毒的人(PLHIV)住院后的死亡率仍然高得惊人。住院是进行有针对性干预的关键时机,但有效方法的证据仍然有限。我们以安德森医疗保健利用模型为框架,进行了一项最佳证据叙述性综述,以研究导致出院后死亡的因素,并评估近期的干预措施。 最新发现:撒哈拉以南非洲地区的PLHIV在出院后3至6个月内有12%至26%的死亡风险。社会和结构障碍——包括贫困、耻辱感、粮食不安全和低自我效能感——是主要的中介因素。我们审查了三种提供家庭支持、咨询和护理联系的非疾病特异性干预措施(HomeLink、Daraja、ReCharge)。虽然这些措施可行且可接受,但由于样本量小和病情严重,对死亡率的影响不一。医院到家庭的过渡是加强差异化服务以降低PLHIV死亡率的关键窗口。需要进一步研究来确定可扩展且具有成本效益的模式,以提高生存率并缩小艾滋病毒护理差距。
Front Public Health. 2025-6-10
Trop Med Int Health. 2015-4
J Acquir Immune Defic Syndr. 2023-11-1
J Grad Med Educ. 2022-8